CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project aims to improve treatment outcomes for patients with metastatic pancreatic ductal adenocarcinoma by investigating the role of microbiota-derived metabolites in enhancing chemotherapy efficacy and boosting anti-tumor immunity. It focuses on understanding differences between responder and non-responder patien…
The prognosis with metastatic pancreatic ductal adenocarcinoma PDAC is simply terrible, especially for those that do not respond to the chemotherapy, which is regarded as the standard therapy in most patients.
More than half of the patients are non-responders and eventually pass away within months.
It is therefore urgently needed to understand the differences among responder and non-responder patients, to develop alternative therapies that overcome the resistance and potentially further extend t…
UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
